Loss of or reduced CADM4 expression has been found in cancer cells, including glioma, prostate cancer, renal cell carcinoma, and non-small cell lung cancer; thus, CADM4 has been recognized as a candidate tumor suppressor [7,9,10]. Here, CADM4 is linked to prostate carcinoma.